After weeks of controversy, the Centers for Medicare and Medicaid Services formally blamed Mylan Pharmaceuticals for misclassifying EpiPen with the Medicaid Drug Rebate Program. Under the program, ...
July 29 (Reuters) - Pfizer Inc has agreed to spin off its off-patent branded drugs business and combine it with generic drugmaker Mylan NV, a move that leaves Pfizer with its more profitable ...
April 13 (Reuters) - Teva Pharmaceutical (TEVA.TA), opens new tab must face a lawsuit claiming it used unlawful methods to block generic competition for its multiple sclerosis drug Copaxone, a New ...
Mylan has spent more than $460 million buying Novartis cystic fibrosis products. Now, it wants the plant that makes them. Mylan took an option on a Novartis plant in San Carlos, California, when it ...
The early reaction to the pairing of generic drug maker Mylan Laboratories and Pfizer’s generics unit, Upjohn — officially announced Monday — is that it’s great for Mylan but maybe not so amazing for ...
Pfizer shareholders would own 57% of the new company and Mylan's shareholders would get 43%. The combined company, which will sell Mylan's EpiPen and Pfizer's Viagra, will be domiciled in the U.S. The ...
A former Mylan information technology executive pleaded guilty to an insider trading scheme in which he acted on tips from another executive ahead of public announcements about earnings, drug ...
Mylan is one of a group of drugmakers that have joined the global effort to supply doses of generic hydroxychloroquine, an antimalarial touted as a possible COVID-19 therapy, to ongoing clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results